 | • レポートコード：MRC2Q12-18912 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、注射用レボホリン酸カルシウムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 注射用レボホリン酸カルシウムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用レボホリン酸カルシウムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用レボホリン酸カルシウムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの注射用レボホリン酸カルシウムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の注射用レボホリン酸カルシウムの売上および2028年までの予測に焦点を当てています。 注射用レボホリン酸カルシウムのグローバル主要企業には、Shanxi PUDE Pharmaceutical、QILU Pharmaceutical、Jiangsu Hengrui Medicine、Jiangsu Chia Tai-Tianqing Pharmaceutical、Guangdong Lingnan Pharmaceutical、Chongqing Huapont Pharmaceutical、Salvavidas Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用レボホリン酸カルシウム市場は、タイプとアプリケーションによって区分されます。世界の注射用レボホリン酸カルシウム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 25mg/ボトル（レボホリン酸換算）、50mg/ボトル（レボホリン酸換算）、150mg/ボトル（レボホリン酸換算） 【アプリケーション別セグメント】 病院薬局、小売薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用レボホリン酸カルシウム製品概要 - タイプ別市場（25mg/ボトル（レボホリン酸換算）、50mg/ボトル（レボホリン酸換算）、150mg/ボトル（レボホリン酸換算）） - アプリケーション別市場（病院薬局、小売薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用レボホリン酸カルシウム販売量予測2017-2028 - 世界の注射用レボホリン酸カルシウム売上予測2017-2028 - 注射用レボホリン酸カルシウムの地域別販売量 - 注射用レボホリン酸カルシウムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用レボホリン酸カルシウム販売量 - 主要メーカー別注射用レボホリン酸カルシウム売上 - 主要メーカー別注射用レボホリン酸カルシウム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（25mg/ボトル（レボホリン酸換算）、50mg/ボトル（レボホリン酸換算）、150mg/ボトル（レボホリン酸換算）） - 注射用レボホリン酸カルシウムのタイプ別販売量 - 注射用レボホリン酸カルシウムのタイプ別売上 - 注射用レボホリン酸カルシウムのタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売薬局、その他） - 注射用レボホリン酸カルシウムのアプリケーション別販売量 - 注射用レボホリン酸カルシウムのアプリケーション別売上 - 注射用レボホリン酸カルシウムのアプリケーション別価格 ・北米市場 - 北米の注射用レボホリン酸カルシウム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用レボホリン酸カルシウム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用レボホリン酸カルシウム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用レボホリン酸カルシウム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用レボホリン酸カルシウム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用レボホリン酸カルシウム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用レボホリン酸カルシウム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用レボホリン酸カルシウム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用レボホリン酸カルシウム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用レボホリン酸カルシウム市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi PUDE Pharmaceutical、QILU Pharmaceutical、Jiangsu Hengrui Medicine、Jiangsu Chia Tai-Tianqing Pharmaceutical、Guangdong Lingnan Pharmaceutical、Chongqing Huapont Pharmaceutical、Salvavidas Pharmaceutical ・産業チェーン及び販売チャネル分析 - 注射用レボホリン酸カルシウムの産業チェーン分析 - 注射用レボホリン酸カルシウムの原材料 - 注射用レボホリン酸カルシウムの生産プロセス - 注射用レボホリン酸カルシウムの販売及びマーケティング - 注射用レボホリン酸カルシウムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用レボホリン酸カルシウムの産業動向 - 注射用レボホリン酸カルシウムのマーケットドライバー - 注射用レボホリン酸カルシウムの課題 - 注射用レボホリン酸カルシウムの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Calcium Levofolinate for Injection Market
Due to the COVID-19 pandemic, the global Calcium Levofolinate for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 25mg/Bottle (Calculated As Levofolic Acid) accounting for % of the Calcium Levofolinate for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Calcium Levofolinate for Injection market size is valued at US$ million in 2021, while the US and Europe Calcium Levofolinate for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Calcium Levofolinate for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Calcium Levofolinate for Injection include Shanxi PUDE Pharmaceutical, QILU Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Chia Tai-Tianqing Pharmaceutical, Guangdong Lingnan Pharmaceutical, Chongqing Huapont Pharmaceutical and Salvavidas Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Calcium Levofolinate for Injection Scope and Segment
Calcium Levofolinate for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Calcium Levofolinate for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
25mg/Bottle (Calculated As Levofolic Acid)
50mg/Bottle (Calculated As Levofolic Acid)
150mg/Bottle (Calculated As Levofolic Acid)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Shanxi PUDE Pharmaceutical
QILU Pharmaceutical
Jiangsu Hengrui Medicine
Jiangsu Chia Tai-Tianqing Pharmaceutical
Guangdong Lingnan Pharmaceutical
Chongqing Huapont Pharmaceutical
Salvavidas Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Calcium Levofolinate for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Calcium Levofolinate for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 25mg/Bottle (Calculated As Levofolic Acid)
1.2.3 50mg/Bottle (Calculated As Levofolic Acid)
1.2.4 150mg/Bottle (Calculated As Levofolic Acid)
1.3 Market by Application
1.3.1 Global Calcium Levofolinate for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Calcium Levofolinate for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Calcium Levofolinate for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Calcium Levofolinate for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Calcium Levofolinate for Injection Sales by Region
2.4.1 Global Calcium Levofolinate for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Calcium Levofolinate for Injection by Region (2023-2028)
2.5 Global Calcium Levofolinate for Injection Revenue by Region
2.5.1 Global Calcium Levofolinate for Injection Revenue by Region (2017-2022)
2.5.2 Global Calcium Levofolinate for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Calcium Levofolinate for Injection Sales by Manufacturers
3.1.1 Global Top Calcium Levofolinate for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Calcium Levofolinate for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Calcium Levofolinate for Injection in 2021
3.2 Global Calcium Levofolinate for Injection Revenue by Manufacturers
3.2.1 Global Calcium Levofolinate for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Calcium Levofolinate for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Calcium Levofolinate for Injection Revenue in 2021
3.3 Global Calcium Levofolinate for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Calcium Levofolinate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Calcium Levofolinate for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Calcium Levofolinate for Injection Sales by Specification
4.1.1 Global Calcium Levofolinate for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Calcium Levofolinate for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Calcium Levofolinate for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Calcium Levofolinate for Injection Revenue by Specification
4.2.1 Global Calcium Levofolinate for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Calcium Levofolinate for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Calcium Levofolinate for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Calcium Levofolinate for Injection Price by Specification
4.3.1 Global Calcium Levofolinate for Injection Price by Specification (2017-2022)
4.3.2 Global Calcium Levofolinate for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Calcium Levofolinate for Injection Sales by Application
5.1.1 Global Calcium Levofolinate for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Calcium Levofolinate for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Calcium Levofolinate for Injection Sales Market Share by Application (2017-2028)
5.2 Global Calcium Levofolinate for Injection Revenue by Application
5.2.1 Global Calcium Levofolinate for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Calcium Levofolinate for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Calcium Levofolinate for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Calcium Levofolinate for Injection Price by Application
5.3.1 Global Calcium Levofolinate for Injection Price by Application (2017-2022)
5.3.2 Global Calcium Levofolinate for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Calcium Levofolinate for Injection Market Size by Specification
6.1.1 North America Calcium Levofolinate for Injection Sales by Specification (2017-2028)
6.1.2 North America Calcium Levofolinate for Injection Revenue by Specification (2017-2028)
6.2 North America Calcium Levofolinate for Injection Market Size by Application
6.2.1 North America Calcium Levofolinate for Injection Sales by Application (2017-2028)
6.2.2 North America Calcium Levofolinate for Injection Revenue by Application (2017-2028)
6.3 North America Calcium Levofolinate for Injection Market Size by Country
6.3.1 North America Calcium Levofolinate for Injection Sales by Country (2017-2028)
6.3.2 North America Calcium Levofolinate for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Calcium Levofolinate for Injection Market Size by Specification
7.1.1 Europe Calcium Levofolinate for Injection Sales by Specification (2017-2028)
7.1.2 Europe Calcium Levofolinate for Injection Revenue by Specification (2017-2028)
7.2 Europe Calcium Levofolinate for Injection Market Size by Application
7.2.1 Europe Calcium Levofolinate for Injection Sales by Application (2017-2028)
7.2.2 Europe Calcium Levofolinate for Injection Revenue by Application (2017-2028)
7.3 Europe Calcium Levofolinate for Injection Market Size by Country
7.3.1 Europe Calcium Levofolinate for Injection Sales by Country (2017-2028)
7.3.2 Europe Calcium Levofolinate for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Calcium Levofolinate for Injection Market Size by Specification
8.1.1 Asia Pacific Calcium Levofolinate for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Calcium Levofolinate for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Calcium Levofolinate for Injection Market Size by Application
8.2.1 Asia Pacific Calcium Levofolinate for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Calcium Levofolinate for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Calcium Levofolinate for Injection Market Size by Region
8.3.1 Asia Pacific Calcium Levofolinate for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Calcium Levofolinate for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Calcium Levofolinate for Injection Market Size by Specification
9.1.1 Latin America Calcium Levofolinate for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Calcium Levofolinate for Injection Revenue by Specification (2017-2028)
9.2 Latin America Calcium Levofolinate for Injection Market Size by Application
9.2.1 Latin America Calcium Levofolinate for Injection Sales by Application (2017-2028)
9.2.2 Latin America Calcium Levofolinate for Injection Revenue by Application (2017-2028)
9.3 Latin America Calcium Levofolinate for Injection Market Size by Country
9.3.1 Latin America Calcium Levofolinate for Injection Sales by Country (2017-2028)
9.3.2 Latin America Calcium Levofolinate for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Calcium Levofolinate for Injection Market Size by Specification
10.1.1 Middle East and Africa Calcium Levofolinate for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Calcium Levofolinate for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Calcium Levofolinate for Injection Market Size by Application
10.2.1 Middle East and Africa Calcium Levofolinate for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Calcium Levofolinate for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Calcium Levofolinate for Injection Market Size by Country
10.3.1 Middle East and Africa Calcium Levofolinate for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Calcium Levofolinate for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi PUDE Pharmaceutical
11.1.1 Shanxi PUDE Pharmaceutical Corporation Information
11.1.2 Shanxi PUDE Pharmaceutical Overview
11.1.3 Shanxi PUDE Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi PUDE Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi PUDE Pharmaceutical Recent Developments
11.2 QILU Pharmaceutical
11.2.1 QILU Pharmaceutical Corporation Information
11.2.2 QILU Pharmaceutical Overview
11.2.3 QILU Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 QILU Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 QILU Pharmaceutical Recent Developments
11.3 Jiangsu Hengrui Medicine
11.3.1 Jiangsu Hengrui Medicine Corporation Information
11.3.2 Jiangsu Hengrui Medicine Overview
11.3.3 Jiangsu Hengrui Medicine Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Jiangsu Hengrui Medicine Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Hengrui Medicine Recent Developments
11.4 Jiangsu Chia Tai-Tianqing Pharmaceutical
11.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
11.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Overview
11.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
11.5 Guangdong Lingnan Pharmaceutical
11.5.1 Guangdong Lingnan Pharmaceutical Corporation Information
11.5.2 Guangdong Lingnan Pharmaceutical Overview
11.5.3 Guangdong Lingnan Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Guangdong Lingnan Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Guangdong Lingnan Pharmaceutical Recent Developments
11.6 Chongqing Huapont Pharmaceutical
11.6.1 Chongqing Huapont Pharmaceutical Corporation Information
11.6.2 Chongqing Huapont Pharmaceutical Overview
11.6.3 Chongqing Huapont Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Chongqing Huapont Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Chongqing Huapont Pharmaceutical Recent Developments
11.7 Salvavidas Pharmaceutical
11.7.1 Salvavidas Pharmaceutical Corporation Information
11.7.2 Salvavidas Pharmaceutical Overview
11.7.3 Salvavidas Pharmaceutical Calcium Levofolinate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Salvavidas Pharmaceutical Calcium Levofolinate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Salvavidas Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Calcium Levofolinate for Injection Industry Chain Analysis
12.2 Calcium Levofolinate for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Calcium Levofolinate for Injection Production Mode & Process
12.4 Calcium Levofolinate for Injection Sales and Marketing
12.4.1 Calcium Levofolinate for Injection Sales Channels
12.4.2 Calcium Levofolinate for Injection Distributors
12.5 Calcium Levofolinate for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Calcium Levofolinate for Injection Industry Trends
13.2 Calcium Levofolinate for Injection Market Drivers
13.3 Calcium Levofolinate for Injection Market Challenges
13.4 Calcium Levofolinate for Injection Market Restraints
14 Key Findings in The Global Calcium Levofolinate for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer